Samsung Biologics Reports Second Quarter 2023 Financial Results

Recorded Q2'23 consolidated revenue of KRW 866.2 billionRecorded Q2'23 consolidated operating profit of KRW 253.4 billionAchieved record-high semi...

Related Keywords

Incheon ,Inch On Gwangyoksi ,South Korea ,Samsung Biologics America ,Claire Kim ,Samsung Biologics ,Pfizer ,Samsung Biologics Co Ltd ,Novartis ,John Rim ,Bio Campus ,Samsung Biologic ,Biologics Contact ,